logo
logo

Opiant Pharmaceuticals Announces Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition By Indivior Plc

Opiant Pharmaceuticals Announces Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition By Indivior Plc

02/06/23, 1:03 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsanta monica
Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) announced today the expiration of the waiting period under the United States (U.S.) Hart-Scott-Rodino Act of 1976, as amended (HSR Act), with respect to the previously announced agreement for Opiant to be acquired by Indivior PLC (LSE: INDV).

Company Info

Company
Indivior PLC
Company info
Learn more about how INSUPPORT® can help streamline the access and reimbursement process for appropriate eligible patients.

Related People